Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
Donald 1 Twito. MD. and B. J. Kennedy. MD. Section of Medical Oncology, Department of Medicine, University of Minnesota School of Medicine, Minneapolis, Minnesota 55455 Carcinoma of the testis is one of the most common forms of lethal malignancy encountered in males IS to 40 years of age (Table 1). The average annual age adjusted incidence rate for all races is 3.1 per 100,000 males (1). Although occurring at all ages, it ranks first in incidence rate in males 20 to 34 years of age and accounts for 11.4% of all cancer deaths in the 25-34 age group (2). Approximately 1 % of all malignant tumors in males originate in the testis, accounting for 0.6% of all fatal tumors in males (2). The probability at birth of developing cancer of the testis is 0.16% compared to 5.5% for female breast cancer and 2.5% for lung cancer (2). It is nearly three times more common in whites than non-whites. Cancer of the testis has a significant impact on the social, economic, and emo tional status of this young population. There is no doubt that the prevalence of this type of cancer has been underemphasized and the public uninformed. The
Annual Review of Medicine – Annual Reviews
Published: Feb 1, 1975
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.